Who are we & what's our mission
Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort.
We are a Belgian, award-winning, ISO13485 certified medical device company active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment.
Novosanis prospers in user-friendly and clever medical devices meeting all regulatory and quality requirements, solutions that can improve the accuracy and standardization of the diagnostic test and drug delivery while making the handling easier, more consistent and more comfortable for the person.
We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery of e.g. therapeutic, prophylactic and allergy vaccines in the dermal layer of the skin and Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases and early stage cancer. Colli-Pee™ is in a commercial stage.
What we've been up to
Aim: Performance of a new first-void collection device, Colli-Pee™
- Group A: 32 women, positive for HPV16 and/or 18 at earlier testing (HPV DNA on cervical samples).
- Group B: 155 healthy volunteers (50 men, 105 women), HPV status unknown.
- Detection of hDNA and HPV DNA in (first void) urine collected using Colli-Pee™ (Novosanis) and Multi-Collect™ (Abbott).
Conclusion: In women, urine collected using the Colli-Pee™device yielded a higher number of copies of hDNA and HPV DNA compared to the Abbott Multi-Collect™ system.